(Press-News.org) Charlottesville, VA (August 1, 2014). The Journal of Neurosurgery is pleased to announce today's publication of a supplement to the August issue entitled "Race Against the Clock: Overcoming Challenges in the Management of Anticoagulant-Associated Intracerebral Hemorrhage." Authored by Peter Le Roux, MD, Charles V. Pollack, Jr., MA, MD, Melissa Milan, MD, and Alisa Schaefer, PhD, the 20-page supplement covers the current knowledge of anticoagulant-associated intracerebral hemorrhage (AAICH) and methods in use for management of the condition. Provided by Paradigm Medical Communications, LLC, and supported by an educational grant from CSL Behring, the supplement is freely available for online review and download: http://thejns.org/toc/sup/121/Suppl. Continuing medical education (CME) credits are available to those who wish to avail themselves of the opportunity.
Intracerebral hemorrhage (ICH) is a potentially deadly form of hemorrhagic stroke. A medical emergency, ICH occurs when blood escapes into brain tissue from an injured or diseased blood vessel. Increased blood in the brain builds up pressure within the skull, which can cause unconsciousness and death. Interruption of normal blood flow deprives parts of the brain of the oxygen that is required. Degradation of pooled blood products in the brain damages and can kill brain cells. To reduce the harmful effects of ICH, swift medical and/or surgical treatment is essential. Nevertheless, more than one-third of patients will not survive and only 20% of patients will regain functional independence following ICH.
Management of ICH poses a greater challenge when it occurs in patients who receive anticoagulation therapy, because the decreased ability of blood to clot leads to larger hemorrhages. Anticoagulants are prescribed for a variety of diagnoses such as atrial fibrillation, deep vein thrombosis, heart attack, and ischemic stroke. These diseases are found more frequently in older individuals, and the aging population keeps increasing. Consequently, the number of cases of anticoagulant-associated ICH (AAICH) is on the rise. Dr. LeRoux and colleagues cite a mortality rate for AAICH "as high as 42.3% to 67%"—substantially higher than that of ICH as a whole. Such numbers indicate a great need to improve the treatment of AAICH.
"Race Against the clock" conveys the urgency involved in reversing the effect of anticoagulant medications in patients with ICH. In this educational supplement, Dr. Le Roux and colleagues have compiled up-to-date information on AAICH and its treatment. They offer a review of current oral anticoagulation therapies and describe various agents' mechanisms of action. Beginning with warfarin, the most well known and widely used anticoagulation agent, the authors move through newer oral anticoagulants such as the direct thrombin inhibitor dabigatran etexilate and the direct factor Xa inhibitors rivaroxaban and apixaban.
The authors review administration of vitamin K, fresh frozen plasma, prothrombin complex concentrates (both three-factor [used off label] and four-factor PCCs), and recombinant factor VIIa, as well as the use of dialysis, in reversing the effects of anticoagulants. Reversal of warfarin's effects has been widely tested, and the supplement offers a sample protocol for this. There are far fewer studies of reversal of the targeted oral anticoagulants (dabigatran etexilate, rivaroxaban, and apixaban), for which no specific antidotes have been identified as yet. The authors describe current and potential treatments used in cases of AAICH involving these agents.
The authors review the American Heart Association–American Stroke Association Guidelines for the management of spontaneous ICH. These AHA Guidelines include reversal strategies for AAICH but were written before the newer oral anticoagulants were approved for use. The authors point out that investigations of ICH treatment are ongoing and discuss a number of recent clinical trials. Also discussed are surgery for AAICH and the controversy over when to restart oral anticoagulation therapy following AAICH.
Institutional protocols for the treatment of spontaneous ICH and AAICH, involving a multidisciplinary approach, are discussed and their development in individual institutions is strongly recommended.
INFORMATION:
Learning Objectives
As noted earlier, CME credits are offered to those interested. Once "Race against the clock" is carefully reviewed, the authors believe that the reader should be able to do the following:
"Appropriately apply evidence-based guidelines and strategies to the management of patients with warfarin-associated ICH.
"Recognize the barriers to successful management of patients with ICH in the context of anticoagulation-associated coagulopathy.
"Based on risk/benefit analysis of reversal agents, select appropriate therapies for the treatment of patients with AAICH."
Le Roux P, Pollack CV Jr., Milan M, and Schaefer A. Race against the clock: Overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. Supplement to the Journal of Neurosurgery 121:1, 2014.
For additional information, please contact:
Ms. Jo Ann M. Eliason, Communications Manager
Journal of Neurosurgery Publishing Group
One Morton Drive, Suite 200, Charlottesville, VA 22903
Email: jaeliason@thejns.org Phone 434-982-1209; Fax 434-924-2702
For 70 years, the Journal of Neurosurgery has been recognized by neurosurgeons and other medical specialists the world over for its authoritative clinical articles, cutting-edge laboratory research papers, renowned case reports, expert technical notes, and more. Each article is rigorously peer reviewed. The Journal of Neurosurgery is published monthly by the JNS Publishing Group, the scholarly journal division of the American Association of Neurological Surgeons. Other peer-reviewed journals published by the JNS Publishing Group each month include Neurosurgical Focus, the Journal of Neurosurgery: Spine, and the Journal of Neurosurgery: Pediatrics. All four journals can be accessed at http://www.thejns.org.
Founded in 1931 as the Harvey Cushing Society, the American Association of Neurological Surgeons (AANS) is a scientific and educational association with more than 8,300 members worldwide. The AANS is dedicated to advancing the specialty of neurological surgery in order to provide the highest quality of neurosurgical care to the public. All active members of the AANS are certified by the American Board of Neurological Surgery, the Royal College of Physicians and Surgeons (Neurosurgery) of Canada or the Mexican Council of Neurological Surgery, AC. Neurological surgery is the medical specialty concerned with the prevention, diagnosis, treatment and rehabilitation of disorders that affect the entire nervous system including the brain, spinal column, spinal cord, and peripheral nerves. For more information, visit http://www.AANS.org.
Management of anticoagulant-associated intracerebral hemorrhage
2014-08-01
ELSE PRESS RELEASES FROM THIS DATE:
Scientists warn time to stop drilling in the dark
2014-08-01
The co-authors of a new study, including two Simon Fraser University research associates, cite new reasons why scientists, industry representatives and policymakers must collaborate closely on minimizing damage to the natural world from shale gas development. Viorel Popescu and Maureen Ryan, David H. Smith Conservation Research Fellows in SFU's Biological Sciences department, are among eight international co-authors of the newly published research in Frontiers in Ecology and the Environment.
Shale gas development is the extraction of natural gas from shale formations ...
Female baby boomers with asthma? You may need help
2014-08-01
ARLINGTON HEIGHTS, Ill. (August 1, 2014) – Women over the age of 65 face numerous barriers to good health: an increased risk for obesity, greater struggles against poverty and higher rates of asthma with worse health outcomes. An article published in the August issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), outlines the challenges faced by older women in treating asthma, and offers practical solutions to improve their care.
"Allergists want older women to understand that ...
New guidelines help keep asthma out of 'yellow zone'
2014-08-01
ARLINGTON HEIGHTS, Ill. (August 1, 2014) – If you have asthma, you may have an asthma action plan with a "stoplight system" to help you recognize and respond to changes and understand when symptoms are getting worse and need more attention. If you're in the green zone, you're doing well, yellow means your asthma has worsened and action is needed, and red means you require urgent care. New guidelines are now available to help your allergist steer you out of the yellow zone, back into green and away from the red zone.
"Management of acute loss of asthma control in the ...
Recent use of some birth control pills may increase breast cancer risk
2014-08-01
PHILADELPHIA — Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
"Our results suggest that use of contemporary oral contraceptives [birth control pills] in the past year is associated with an increased breast cancer risk relative to never or former oral contraceptive use, and that this risk may vary by oral contraceptive ...
Light pulses control graphene's electrical behavior
2014-08-01
CAMBRIDGE, Mass-- Graphene, an ultrathin form of carbon with exceptional electrical, optical, and mechanical properties, has become a focus of research on a variety of potential uses. Now researchers at MIT have found a way to control how the material conducts electricity by using extremely short light pulses, which could enable its use as a broadband light detector.
The new findings are published in the journal Physical Review Letters, in a paper by graduate student Alex Frenzel, Nuh Gedik, and three others.
The researchers found that by controlling the concentration ...
'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown
2014-08-01
In the United States, natural-gas production from shale rock has increased by more than 700 percent since 2007. Yet scientists still do not fully understand the industry's effects on nature and wildlife, according to a report in the journal Frontiers in Ecology and the Environment.
As gas extraction continues to vastly outpace scientific examination, a team of eight conservation biologists from various organizations and institutions, including Princeton University, concluded that determining the environmental impact of gas-drilling sites — such as chemical contamination ...
For bats and dolphins, hearing gene prestin adapted for echolocation
2014-08-01
A little over a decade ago, prestin was found to be a key gene responsible for hearing in mammals. Prestin makes a protein found in the hair cells of the inner ear that contracts and expands rapidly to transmit signals that help the cochlea, like an antique phonograph horn, amplify sound waves to make hearing more sensitivity.
Now, in a new study published in the advanced online edition of Molecular Biology and Evolution, Peng Shi, et al., have shown that prestin has also independently evolved to play a critical role in the ultrasonic hearing range of animal sonar, ...
Scientist underlines threat of inevitable 'solar super-storms'
2014-08-01
In this month's issue of Physics World, Ashley Dale from the University of Bristol warns of the "catastrophic" and "long-lasting" impacts of "solar super-storms" and the dangers we face if the threat continues to go unnoticed.
Dale, who was a member of an international task force – dubbed SolarMAX – set up to identify the risks of a solar storm and how its impact could be minimized, explains how it is only a matter of time before an exceptionally violent solar storm is propelled towards Earth. Such a storm would wreak havoc with our communication systems and power supplies, ...
Harmful drinkers would be affected 200 times more than low risk drinkers with an MUP
2014-08-01
A new study of liver patients by the University of Southampton shows that a Minimum Unit Price (MUP) policy for alcohol is exquisitely targeted towards the heaviest drinkers with cirrhosis.
Published today in Clinical Medicine, the peer review journal for the Royal College of Physicians, the researchers studied the amount and type of alcohol drunk by 404 liver patients, and also asked patients how much they paid for alcohol. They found that patients with alcohol related cirrhosis were drinking on average the equivalent of four bottles of vodka each week, and were buying ...
Depressive symptoms and pain may affect health outcomes in dialysis patients
2014-08-01
Washington, DC (July 31, 2014) — Depressive symptoms and pain in patients on dialysis may have serious negative consequences for patients' health and increase the need for costly medical services, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The findings indicate that studies should evaluate the potential of anti-depressant and analgesic therapies to improve patient outcomes and reduce costs.
Depressive symptoms and pain are common in kidney failure patients receiving chronic hemodialysis, but ...